ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 10 filers reported holding ACORDA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $9,828,000 | +103.0% | 10,080,000 | +39.4% | 0.10% | +71.9% |
| Q4 2020 | $4,842,000 | -7.7% | 7,230,000 | +7.4% | 0.06% | -24.0% |
| Q3 2020 | $5,248,000 | -9.9% | 6,730,000 | 0.0% | 0.08% | -46.8% |
| Q2 2020 | $5,823,000 | -0.7% | 6,730,000 | 0.0% | 0.14% | -9.6% |
| Q1 2020 | $5,862,000 | +967.8% | 6,730,000 | +821.9% | 0.16% | +1200.0% |
| Q4 2019 | $549,000 | -95.4% | 730,000 | -95.2% | 0.01% | -94.8% |
| Q3 2019 | $11,830,000 | -8.0% | 15,120,000 | 0.0% | 0.23% | +65.7% |
| Q2 2019 | $12,861,000 | -3.6% | 15,120,000 | 0.0% | 0.14% | -45.3% |
| Q1 2019 | $13,343,000 | +101.6% | 15,120,000 | +89.0% | 0.26% | +96.9% |
| Q4 2018 | $6,619,000 | -21.6% | 8,000,000 | -20.0% | 0.13% | +41.3% |
| Q3 2018 | $8,440,000 | -35.3% | 10,000,000 | -25.9% | 0.09% | -39.9% |
| Q2 2018 | $13,047,000 | -28.2% | 13,500,000 | -32.5% | 0.15% | -20.3% |
| Q1 2018 | $18,178,000 | +7.3% | 20,000,000 | 0.0% | 0.19% | -16.5% |
| Q4 2017 | $16,938,000 | +25.1% | 20,000,000 | +33.3% | 0.23% | +27.1% |
| Q3 2017 | $13,538,000 | -21.1% | 15,000,000 | -25.0% | 0.18% | -23.3% |
| Q2 2017 | $17,163,000 | +1.0% | 20,000,000 | 0.0% | 0.24% | +20.4% |
| Q1 2017 | $17,000,000 | +11.8% | 20,000,000 | 0.0% | 0.20% | -36.4% |
| Q4 2016 | $15,200,000 | -6.7% | 20,000,000 | 0.0% | 0.31% | -23.0% |
| Q3 2016 | $16,293,000 | +24.3% | 20,000,000 | +33.3% | 0.40% | +29.9% |
| Q2 2016 | $13,111,000 | -26.4% | 15,000,000 | -25.0% | 0.31% | -18.5% |
| Q1 2016 | $17,802,000 | -38.1% | 20,000,000 | -20.0% | 0.38% | -26.5% |
| Q4 2015 | $28,767,000 | +58.3% | 25,000,000 | +25.0% | 0.51% | +60.1% |
| Q3 2015 | $18,167,000 | -27.9% | 20,000,000 | -20.0% | 0.32% | -22.3% |
| Q2 2015 | $25,188,000 | -1.2% | 25,000,000 | 0.0% | 0.41% | -23.4% |
| Q1 2015 | $25,492,000 | +11.2% | 25,000,000 | +25.0% | 0.54% | +25.6% |
| Q4 2014 | $22,932,000 | +38.5% | 20,000,000 | +25.0% | 0.43% | +13.5% |
| Q3 2014 | $16,560,000 | – | 16,000,000 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 3,586,000 | $3,237,000 | 2.17% |
| Telemetry Investments, L.L.C. | 4,000,000 | $3,610,000 | 1.29% |
| Castle Creek Arbitrage, LLC | 6,000,000 | $5,419,000 | 0.54% |
| Man Investments (CH) AG | 600,000 | $542,000 | 0.46% |
| SSI INVESTMENT MANAGEMENT LLC | 5,683,000 | $5,129,000 | 0.44% |
| CANYON CAPITAL ADVISORS LLC | 29,000,000 | $26,173,000 | 0.39% |
| PFM Health Sciences, LP | 21,362,000 | $19,386,000 | 0.38% |
| IRON Financial LLC | 500,000 | $454,000 | 0.35% |
| Partner Investment Management, L.P. | 373,000 | $338,000 | 0.32% |
| WOLVERINE ASSET MANAGEMENT LLC | 29,555,000 | $26,667,000 | 0.30% |